Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
6h
Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow
Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Next Senate majority leader
Consumer inflation picks up
Died of septic shock
‘I was not paid a dime’
Pleads guilty to $2B fraud
Jack Smith to resign?
Kidnappers get 30 yrs in jail
Takes job outside WH
Dozens killed in China
Repairs to cost nearly $56M
On Jan. 6 ‘parading’ charge
Tests negative for rabies
Amtrak service disrupted
Recalling pickups, SUVs
Kentucky plant explosion
Nvidia chips for SoftBank
Meets w/ president of Israel
Bid to delay trial rejected
Picked as defense secretary
To lead new department
Wins the Booker Prize 2024
Paulson exits Treasury race
Ratcliffe named CIA director
STD epidemic slows
Suspect waives jury trial
UFO hearing today
Issues resolved after outage
To file for bankruptcy?
Feedback